RA CAPITAL MANAGEMENT, L.P. received a stock award from ACRIVON THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/20/2026ACC: 0001231919-26-000517
Director10% Owner
Since Nov 2022
+9.37K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
9.37K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+9.37K
Price / share
—
Trade value
—
% of position
New position
5/18/2026
0.00→9.37K
Total
Net shares
+9.37K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/18/2026 | A · Award | +9.37K | — | — | New position | 0.00 | 9.37K |
| Total | +9.37K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned426.30K
Common Stock
IndirectShares owned11.80M
Total
12.23M indirect12.23M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 426.30K | Indirect |
| Common Stock | 11.80M | Indirect |
| Total | 12.23M | 12.23M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported